Detection and characterization of DNA adducts of 3-methylindole

Chemical Research in Toxicology

Volumn 14, Issue 8, 2001, Pages 1014-1024

  Regal, K A ^a   Laws, G M ^a   Yuan, C ^b   Yost, G S ^b   Skiles, G L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; GLUTATHIONE; NUCLEOSIDE; PROTEIN; SKATOLE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; DNA ADDUCT; DNA CLEAVAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN SYNTHESIS; RAT; REACTION ANALYSIS; SOLID PHASE EXTRACTION;

ANIMALS; CARCINOGENS; DNA ADDUCTS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MICROSOMES; NUCLEOSIDES; RATS; SKATOLE; SPECTROMETRY, MASS, SECONDARY ION;

EID: 0034865895     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0100237     Document Type: Article

References (57)

1. 3-Methylindole-induced acute lung injury resulting from ruminal fermentation of tryptophan
2. Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole
3. Evidence supporting the formation of 2,3-epoxy-3-methylindoline: A reactive intermediate of the pneumotoxin 3-methylindole
4. Thioether adducts of a new imine reactive intermediate of the pneumotoxin 3-methylindole
5. Identifcation of phase I metabolites of 3-methylindole produced by pig liver microsomes
6. Metabolic fate of 3-methylindole in goats and mice
7. Isolation and identification of 3-hydroxy-3-methylindole, the major murine metabolite of 3-methylindole
8. Metabolism of 3-methylindole in human tissues
9. Metabolism and bioactivation of 3-methylindole by Clara cells, alveolar macrophages and subcellular fractions from rabbit lungs
10. Glutathione adduct formation with microsomally activated metabolites of the pulmonary alkylating and cytotoxic agent, 3-methylindole
11. Mechanisms of 3-methylindole pneumotoxicity
12. Selected nontherapeutie agents
13. Cause and prevention of acute pulmonary edema and emphysema in cattle
14. Ultrastructural pulmonary changes induced by intravenously administered 3-methylindole in goats
15. Effect of glutathione status on covalent binding and pneumotoxicity of 3-methylindole in goats
16. Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene
17. Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells
18. Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome P450 enzymes
19. Pathology and glutathione status in 3-methylindole treated rodents
20. Bioactivation of 3-methylindole by isolated rabbit lung cells
21. Identification of a cystinyl adduct of oxidized 3-methylindole isolated from goat lung and human liver microsomal proteins
22. Isolation of a mercapturate adduct produced subsequent to glutathione conjugation of bioactivated 3-methylindole
23. Production and characterization of specific antibodies: Utilization to predict organ- and species-selective pneumotoxicity of 3-methylindole
24. Decreased pneumotoxicity of deuterated 3-methylindole: Bioactivation requires methyl C-H bond breakage
25. Oligomerization of indole-3-carbinol in aqueous acid
26. The effect of oral phenobarbitone on hepatic microsomal cytochrome P-450 and demethylation activity in rats fed normal and low protein diets
27. A safe substitute for polychlorinated biphenyls as an inducer of the metabolic activation system
28. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test
29. DNA conformation assay: Determination of in vitro DNA adduct formation and strand breaks
30. Measurement of 8-OHdG in DNA by HPLC/ECD: The importance of DNA purity
31. Isolation and use of liver cells
32. 32P-postlabeling and multifraction contact-transfer thin-layer chromatography
33. DNA alkylation by 4,5-dioxovaleric acid, the final oxidation product of 5-aminolevulinic acid
34. Reaction of potential bacterial mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) with 2′-deoxyadenosine and calf thymus DNA: Identification of fluorescent propenoformyl derivatives
35. Alkylation of 2′-deoxynucleosides and DNA by the premarin metabolite 4-hydroxyequilenin semiquinone radical
36. 32P-postlabeling test for structurally diverse DNA adducts
37. Microbial metabolites of tryptophan in the intestinal tract with special reference to skatole
38. Fecal skatole and indole and breath methane and hydrogen in patients with large bowel polyps or cancer
39. Heterocyclic nitrogen compounds
40. Quantitative determination of 1-alkylindoles in cigarette smoke
41. Certain constituents of tobacco products
42. Role of covalent and noncovalent interactions in cellular toxicity: Effects on proteins
43. Mechanisms of aflatoxin carcinogenesis
44. Toxicology and epidemiology of 1,3-butadiene
45. Characterization of reaction products between styrene oxide and deoxynucleosides and DNA
46. Sequence context profoundly influences the mutagenic potency of trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-purine nucleoside adducts in site-specific mutation studies
47. Sequence context effects on mutational properties of cis-opened benzo[c]phenanthrene diol epoxidedeoxyadenoxine adducts in site-specific mutation studies
48. Targeted AT and GT mutations induced by site-specific deoxyadenosine and deoxyguanosine adducts, respectively, from the (+)-anti-diol epoxide of dibenz[a,j]anthracene in M13mp7L2
49. DNA adducts with p53 induction and delay of MCF-7 cells in S phase after exposure to benzo[g]chrysene dihydrodiol epoxide enantiomers
50. What is the significance of increases in background levels of carcinogen-derived protein and DNA adducts? Some considerations for incremental risk assessment
51. Correlation of DNA adduct levels with tumor incidence: Carcinogenic potency of DNA adducts
52. Prediction of nucleoside-carcinogen reactivity. Alkylation of adenine, cytosine, guanine and thymine and their deoxynucleosides by alkanediazonium ions
53. Chemical and physical carcinogenesis: Advances and perspectives for the 1990s
54. The major mitomycin C-DNA adduct is cytotoxic but not mutagenic in Escherichia coli
55. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
56. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
57. 3-Methylindole (3MI) causes both apoptosis and necrosis in cultured human lung cells